Results 151 to 160 of about 2,703,409 (308)
This multi‐institutional study evaluated the Geriatric Nutritional Risk Index (GNRI) in 225 nonagenarians undergoing surgical resection for colorectal cancer. A lower preoperative GNRI was independently associated with a longer hospital stay and poorer overall survival, even after adjustment for confounders using inverse‐probability‐of‐treatment ...
Toshiaki Toshima +19 more
wiley +1 more source
Traditionally, the therapeutic approach to rectal cancer has involved neoadjuvant chemoradiotherapy followed by surgical resection, and, in some cases, adjuvant chemotherapy.
Roxana Elena Stefan +7 more
doaj +1 more source
Item‐level factor analysis of the LARS and Wexner scores in 320 patients undergoing sphincter‐preserving rectal resection identified three distinct symptom domains: incontinence, urgency/clustering, and gas control. These domains had different clinical determinants: radiotherapy was associated with greater severity of both incontinence and urgency ...
Yoshiko Matsumoto +8 more
wiley +1 more source
Current Status of Neoadjuvant Treatment Before Surgery in High-Risk Localized Prostate Cancer
Localized high-risk (HR) prostate cancer (PCa) is a heterogeneous disease whose likelihood of a biochemical recurrence, metastatic progression and cancer-related mortality after initial treatment is higher when compared with patients with low (LR) or ...
Luis Enrique Ortega Polledo +11 more
core +1 more source
Robot‐assisted pelvic exenteration (RPE) was performed with acceptable perioperative outcomes in selected patients with primary rectal cancer. It may serve as a complementary approach at institutions with sufficient experience in PE, whereas open surgery remains essential for extensive or technically demanding disease.
Shoma Yamamoto +3 more
wiley +1 more source
ABSTRACT Aim To evaluate the association between preoperative neoadjuvant therapy and short‐term outcomes of transanal total mesorectal excision for rectal cancer. Methods We retrospectively analyzed patients who underwent transanal total mesorectal excision at 26 Japanese institutions between 2012 and 2019.
Takafumi Shima +57 more
wiley +1 more source
Background Tumor recurrence and mortality rates remain challenging in cancer patients despite comprehensive treatment. Neoadjuvant chemotherapy and immunotherapy aim to eliminate residual tumor cells, reducing the risk of recurrence.
Yaoyao Zhou +11 more
doaj +1 more source
In this multicenter study of 507 patients aged ≥ 80 years who underwent curative gastrectomy for gastric cancer, a low preoperative HALP score was independently associated with poor overall survival. This association remained consistent across multiple complementary analyses, and low HALP was also associated with both cancer‐specific and other‐cause ...
Hiroyuki Inoue +16 more
wiley +1 more source
The 3‐year local recurrence (LR), recurrence‐free survival, and overall survival rates were 7.3%, 79.5%, and 98.1%, respectively. Multivariable analysis identified circumferential resection margin (CRM)/radial margin (RM) positivity as an independent risk factor for LR.
Kan Tanabe +12 more
wiley +1 more source
Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?
Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge in oncology due to its advanced stage upon diagnosis and limited treatment options.
Benjelloun El Ghali +4 more
core +1 more source

